A number of medical specialty societies and expert groups have issued guidelines on hereditary cancer testing. Myriad has formed its assessment criteria based on the following medical society guidelines. A healthcare specialist may use assessment criteria based on that specialist’s medical society guidelines, or based on his/her own professional judgment, which may differ from Myriad’s assessment guidelines.
BRACAnalysis® Testing for Hereditary Breast and Ovarian Cancer (HBOC)
NCCN – National Comprehensive Cancer Network (login required)
– American Congress of Obstetricians and Gynecologists
– American Society of Breast Surgeons (pdf)
ASCO® – American Society of Clinical Oncology
– Society of Gynecologic Oncology
USPSTF – U.S. Preventive Services Task Force
There may be additional professional practice guidelines for HBOC testing than those listed above that a healthcare specialist may want to consider, including the following:
– Association of Community Cancer Centers
AMA – American Medical Association
NSGC – National Society of Genetic Counselors
ONS – Oncology Nursing Society
– Society of Gynecologic Oncology
– Society of Surgical Oncology
COLARIS® and COLARIS AP® Testing for Lynch syndrome and Polyposis syndromes
– Association of Community Cancer Centers
AMA – American Medical Association
ASCRS – American Society of Colon and Rectal Surgeons
AGA – American Gastroenterological Association
ASCO® – American Society of Clinical Oncology
NCCN – National Comprehensive Cancer Network
NSGC – National Society of Genetic Counselors
ONS – Oncology Nursing Society
